feed,title,long_url,short_url
Benzinga,Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY,https://benzinga.com/news/earnings/22/03/26056290/chemomab-therapeutics-reports-q4-eps-0-02-vs-0-01-yoy,https://bit.ly/3pQ7lF9
